John L. Slebir - 18 Feb 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
SVP General Counsel
Signature
John L. Slebir, by /s/ Trevor Dutcher, Attorney-in-Fact
Issuer symbol
DVAX
Transactions as of
18 Feb 2025
Net transactions value
-$69,279
Form type
4
Filing time
21 Feb 2025, 16:39:58 UTC
Previous filing
18 Feb 2025
Next filing
29 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise +16,667 +66% 41,731 18 Feb 2025 Direct F1
transaction DVAX Common Stock Tax liability $69,279 -5,358 -13% $12.93 36,373 18 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Options Exercise -16,667 -33% 33,333 18 Feb 2025 Common Stock 16,667 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.
F2 Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.